Cases 51 - 60 of 915
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv01367
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THOMSON v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv06111
Plaintiff:
Beverly Thomson
Defendant:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION, AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
OVERTON v. MYLAN LABORATORIES LTD. et al
as 1:2022cv05859
Plaintiff:
JOANNE OVERTON
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv01228
Plaintiff:
Bayer Pharma AG and Bayer AG
Counter Defendant:
Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Counter Claimant:
Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv01226
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CARTER v. MYLAN N.V. et al
as 1:2022cv05561
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
JACQUELINE CARTER
Defendant:
MYLAN N.V., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
TRAUTMAN v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv05471
Plaintiff:
Yvonne Trautman
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DIZINNO v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv05325
Plaintiff:
DORIS DIZINNO
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ANDREOTTI et al v. MYLAN LABORATORIES, LTD. et al
as 1:2022cv05291
Plaintiff:
DAVID ANDREOTTI and LAURIE ANDREOTTI
Defendant:
MYLAN LABORATORIES, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
